{"entity":{"type":"insider","cik":"0001806596","url":"/insider/0001806596","json_url":"/insider/0001806596.json","name":"Moran Kevin Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":12,"first":"2021-03-03","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Moran Kevin Patrick","source":"filing","n_filings":12,"first_seen":"2021-03-03","last_seen":"2026-03-04"}],"transactions":[{"id":5935779,"accession":"0001806596-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001806596-26-000002","line_url":"/filing/0001806596-26-000002#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42442.0,"shares_display":"42,442","price_per_share":8.2659,"price_display":"8.27","price_state":"stated","total_value":350821.3278,"total_display":"350,821.33","total_whole":"350,821","shares_owned_after":411380.0,"shares_owned_after_display":"411,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":4980603,"accession":"0000950170-25-025914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025914","line_url":"/filing/0000950170-25-025914#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.3894,"price_display":"4.39","price_state":"stated","total_value":8778.8,"total_display":"8,778.80","total_whole":"8,779","shares_owned_after":355763.0,"shares_owned_after_display":"355,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-24","scope":"insider"},{"id":2305405,"accession":"0000950170-24-087381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-087381","line_url":"/filing/0000950170-24-087381#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2251.0,"shares_display":"2,251","price_per_share":5.9203,"price_display":"5.92","price_state":"stated","total_value":13326.5953,"total_display":"13,326.60","total_whole":"13,327","shares_owned_after":228763.0,"shares_owned_after_display":"228,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-29","scope":"insider"},{"id":3151437,"accession":"0000950170-24-027253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-027253","line_url":"/filing/0000950170-24-027253#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8902.0,"shares_display":"8,902","price_per_share":4.2025,"price_display":"4.20","price_state":"stated","total_value":37410.655,"total_display":"37,410.66","total_whole":"37,411","shares_owned_after":231014.0,"shares_owned_after_display":"231,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":3151433,"accession":"0000950170-24-027253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027253","line_url":"/filing/0000950170-24-027253#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5798.0,"shares_display":"5,798","price_per_share":4.4812,"price_display":"4.48","price_state":"stated","total_value":25981.9976,"total_display":"25,982.00","total_whole":"25,982","shares_owned_after":239916.0,"shares_owned_after_display":"239,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8629900,"accession":"0001209191-23-043990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043990","line_url":"/filing/0001209191-23-043990","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2212.0,"shares_display":"2,212","price_per_share":6.304068716094033,"price_display":"6.30","price_state":"stated","total_value":13944.6,"total_display":"13,944.60","total_whole":"13,945","shares_owned_after":120714.0,"shares_owned_after_display":"120,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider","n_lines":2},{"id":8545795,"accession":"0001209191-23-038417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038417","line_url":"/filing/0001209191-23-038417#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":6.2944,"price_display":"6.29","price_state":"stated","total_value":100710.4,"total_display":"100,710.40","total_whole":"100,710","shares_owned_after":122926.0,"shares_owned_after_display":"122,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":8288858,"accession":"0001209191-23-016461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016461","line_url":"/filing/0001209191-23-016461#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5968.0,"shares_display":"5,968","price_per_share":6.2833,"price_display":"6.28","price_state":"stated","total_value":37498.7344,"total_display":"37,498.73","total_whole":"37,499","shares_owned_after":138926.0,"shares_owned_after_display":"138,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":8288854,"accession":"0001209191-23-016461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016461","line_url":"/filing/0001209191-23-016461#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7966.0,"shares_display":"7,966","price_per_share":6.2573,"price_display":"6.26","price_state":"stated","total_value":49845.6518,"total_display":"49,845.65","total_whole":"49,846","shares_owned_after":144894.0,"shares_owned_after_display":"144,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6957886,"accession":"0001209191-22-060225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060225","line_url":"/filing/0001209191-22-060225#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4792.0,"shares_display":"4,792","price_per_share":10.6066,"price_display":"10.61","price_state":"stated","total_value":50826.8272,"total_display":"50,826.83","total_whole":"50,827","shares_owned_after":120160.0,"shares_owned_after_display":"120,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6105987,"accession":"0001209191-22-043682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043682","line_url":"/filing/0001209191-22-043682#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2239.0,"shares_display":"2,239","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":24561.83,"total_display":"24,561.83","total_whole":"24,562","shares_owned_after":117452.0,"shares_owned_after_display":"117,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-08-01","scope":"insider"},{"id":6120854,"accession":"0001209191-22-015155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-015155","line_url":"/filing/0001209191-22-015155#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8832.0,"shares_display":"8,832","price_per_share":11.2828,"price_display":"11.28","price_state":"stated","total_value":99649.6896,"total_display":"99,649.69","total_whole":"99,650","shares_owned_after":119691.0,"shares_owned_after_display":"119,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":6120851,"accession":"0001209191-22-015155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015155","line_url":"/filing/0001209191-22-015155#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3473.0,"shares_display":"3,473","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":38862.87,"total_display":"38,862.87","total_whole":"38,863","shares_owned_after":128523.0,"shares_owned_after_display":"128,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":4731175,"accession":"0001209191-21-048738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048738","line_url":"/filing/0001209191-21-048738#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2130.0,"shares_display":"2,130","price_per_share":19.2361,"price_display":"19.24","price_state":"stated","total_value":40972.893,"total_display":"40,972.89","total_whole":"40,973","shares_owned_after":99296.0,"shares_owned_after_display":"99,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"},{"id":4138434,"accession":"0001209191-21-017274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017274","line_url":"/filing/0001209191-21-017274#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":18.2314,"price_display":"18.23","price_state":"stated","total_value":110190.5816,"total_display":"110,190.58","total_whole":"110,191","shares_owned_after":101426.0,"shares_owned_after_display":"101,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider"},{"id":4138433,"accession":"0001209191-21-017274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017274","line_url":"/filing/0001209191-21-017274#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001806596","owner_name":"Moran Kevin Patrick","owner_display_name":"Moran Kevin Patrick","owner_url":"/insider/0001806596","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3327.0,"shares_display":"3,327","price_per_share":18.5693,"price_display":"18.57","price_state":"stated","total_value":61780.0611,"total_display":"61,780.06","total_whole":"61,780","shares_owned_after":107470.0,"shares_owned_after_display":"107,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP, CFO & Treasurer)","n_filings":12,"first_seen":"2021-03-03","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001806596","retrieved_at":"2026-08-22T13:23:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}